ArticleThe oncologist2021

Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review.

David L Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.